Feasibility study of a single‐handed inserter for levonorgestrel 52 mg intrauterine device placement

Autor: David L. Eisenberg, Courtney A. Schreiber, Paul D. Blumenthal, David K. Turok, Andrea I. Olariu, Mitchell D. Creinin

Publikováno v: Reproductive, Female and Child Health, Vol 3, Iss 1, Pp n/a-n/a (2024)

Abstract Objective To assess placement outcomes using a levonorgestrel 52 mg intrauterine device (IUD) inserter designed for single‐handed use. Methods Investigators enroled participants 18–45 years to have the IUD inserted using a redesigned ins

Externí odkaz: https://doaj.org/article/cb1700afc59c4c159506bf2019456326

Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation

Autor: Andrea I. Olariu, Bruce R. Carr, Michael A. Thomas, Mitchell D. Creinin, A. Gangestad, David L. Eisenberg

Publikováno v: Contraception, vol 103, iss 1

Objective Evaluate reproductive function in nulligravid and gravid women after levonorgestrel 52 mg intrauterine system (IUS) discontinuation based on time to pregnancy. Study design We evaluated women participating in the ACCESS IUS multicenter, Pha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be25ec17de96582116a3fb4e172ea27b
https://doi.org/10.1016/j.contraception.2020.09.005

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System

Autor: Stephanie B. Teal, Andrea I. Olariu, Thomas Kimble, Beatrice A. Chen, David K. Turok, Mitchell D. Creinin

Publikováno v: Obstetrics and gynecology, vol 133, iss 1
Teal, Stephanie B; Turok, David K; Chen, Beatrice A; Kimble, Thomas; Olariu, Andrea I; & Creinin, Mitchell D. (2019). Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System.. Obstetrics and gynecology, 133(1), 63-70. doi: 10.1097/aog.0000000000003034. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0f24156x

OBJECTIVE:To assess the 5-year contraceptive efficacy and safety of a levonorgestrel (LNG) 52-mg intrauterine system (IUS) from an ongoing 10-year phase 3 contraceptive trial. METHODS:Study investigators enrolled 1,751 nulliparous and parous females

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f3a4fc8c6e6e556d6e873d66d197db
https://doi.org/10.1097/aog.0000000000003034

Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system

Autor: Stephanie B. Teal, Carolyn Westhoff, Lisa M. Keder, Andrea I. Olariu, Mitchell D. Creinin, A. Gangestad

Publikováno v: Contraception, vol 101, iss 3

Objective To assess 6-year contraceptive efficacy and safety of a levonorgestrel 52 mg intrauterine system (IUS). Study Design We assessed pregnancy rates through 72 months in women aged 16–35 years at enrollment and safety in all participants (age

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0eec66ccf6d92d89d6c24ffca2ead55
https://escholarship.org/uc/item/5kr8h999

BLEEDING PATTERNS FROM MONTHS 60 TO 72 WITH USE OF A LEVONORGESTREL 52 MG INTRAUTERINE SYSTEM

Autor: Mitchell D. Creinin, Michael A. Thomas, Bruce R. Carr, Jeffrey T. Jensen, Andrea I. Olariu, Thomas Kimble

Publikováno v: FERTILITY AND STERILITY, vol 114, iss 3

Author(s): Jensen, Jeffrey T; Carr, Bruce R; Kimble, Thomas D; Thomas, Michael A; Olariu, Andrea I; Creinin, Mitchell D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e48f40ed083b23ed08790bfb97152c91
https://doi.org/10.1016/j.fertnstert.2020.08.056